Healthcare / Health Information ServicesCanadian Sec
$0.03
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 23%
FCF escenarios
weak_data · normalized FCF $-310893.00 · quality 67.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
12/100
F
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$2M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-72.2%
↓Gross Margin
N/A
•Debt/Equity
0.01
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
—
FCF margin
—
FCF / Net income
0.46x
Latest source
Provider fallback
Margin decomposition
Último año: revenue — · net income $-676083.0 · FCF $-310893.0
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Net Income | $-676083.00 | $-676083.00 | $-133037.00 | $-730391.00 | $-655365.00 |
| EBITDA | $-654833.00 | $-654833.00 | $-107063.00 | $-685039.00 | $-617027.00 |
| EPS | -0.01 | -0.01 | — | -0.02 | -0.01 |
| Balance Sheet | |||||
| Debt/Equity | 0.01 | 0.01 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-310893.00 | $-310893.00 | $-35847.00 | $-715152.00 | $-618469.00 |
| Returns | |||||
| ROE | -72.2% | -72.2% | 497.3% | -957.5% | -99.1% |
| Valuation | |||||
| P/B | 1.59 | 1.59 | — | 64.09 | — |
| Growth & Yield | |||||
| EPS Growth | — | — | — | -35.9% | — |
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-82.4%
Start / end P/E
n/dx → n/dx
EPS bridge
n/d → -0.01
Residual
-82.4%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.